BMRN - Biomarin Pharmaceutical Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BMRN - Biomarin Pharmaceutical Inc.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tuck	4/16/2007 4:43:16 PM
	Read Replies (1) of 18

>>BioMarin Announces Proposed Offering of $250 Million Senior Subordinated Convertible Notes Monday April 16, 4:33 pm ET NOVATO, Calif., April 16 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN - News News) announced today that it intends to offer to sell, subject to market and other conditions, $250 million aggregate principal amount of senior subordinated convertible notes due 2017 in an underwritten public offering. The Company intends to grant the underwriters a 13-day option to purchase up to an additional $37.5 million of notes to cover over-allotments. Merrill Lynch & Co. is acting as sole book-running manager of the public offering. Information about the offering is available in the prospectus supplements for the offerings filed with the Securities and Exchange Commission. Copies of the prospectus supplements can be obtained from Merrill Lynch's prospectus department at 4 World Financial Center, New York, NY 10080. A shelf registration statement relating to the securities being offered has been filed with the Securities and Exchange Commission and has become effective. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.<< snip Wow. DEAD thread. BMRN off from a close of $17.83 to $16.90 after hours, as I type. Conversion price not given at this stage. That'll be an important datum in deciding whether or not this AH sell-off is an over-reaction. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next